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 ABSTRACT Relative contributions of folding kinetics versus protein quality control (QC) ac-
tivity in the partitioning of non-native proteins between life and death are not clear. Cystic 
fi brosis transmembrane conductance regulator (CFTR) biogenesis serves as an excellent mod-
el to study this question because folding of nascent CFTR is ineffi cient and deletion of F508 
causes accumulation of CFTRΔF508 in a kinetically trapped, but foldable state. Herein, a 
novel endoplasmic reticulum (ER)-associated Hsp40, DNAJB12 (JB12) is demonstrated to 
play a role in control of CFTR folding effi ciency. JB12 cooperates with cytosolic Hsc70 and the 
ubiquitin ligase RMA1 to target CFTR and CFTRΔF508 for degradation. Modest elevation of 
JB12 decreased nascent CFTR and CFTRΔF508 accumulation while increasing association of 
Hsc70 with ER forms of CFTR and the RMA1 E3 complex. Depletion of JB12 increased CFTR 
folding effi ciency up to threefold and permitted a pool of CFTRΔF508 to fold and escape the 
ER. Introduction of the V510D misfolding suppressor mutation into CFTRΔF508 modestly in-
creased folding effi ciency, whereas combined inactivation of JB12 and suppression of intrin-
sic folding defects permitted CFTRΔF508 to fold at 50% of wild-type effi ciency. Therapeutic 
correction of CFTRΔF508 misfolding in cystic fi brosis patients may require repair of defective 
folding kinetics and suppression of ER QC factors, such as JB12. 
 INTRODUCTION 
 The fatal lung disease cystic fi brosis (CF) is a loss-of-protein-function 
disorder caused by misfolding and premature degradation of the 
cystic fi brosis transmembrane conductance regulator (CFTR). CFTR 
is a Cl- channel that controls hydration of epithelial cell surfaces in 
airways and glands ( Rowe  et al. , 2005 ). Most CF patients inherit the 
CFTRΔF508 mutant allele the protein product of which exhibits sub-
tle folding defects that lead almost all nascent forms to be degraded 
( Cyr, 2005 ). Patients who exhibit partial CFTR function have mild CF 
symptoms, so restoration of CFTRΔF508 activity to modest levels is 
a therapeutic goal. 
 CFTR contains 1480 amino acid residues and has two membrane-
spanning domains (MSDs), two nucleotide-binding domains (NBD), 
and a regulatory domain ( Riordan  et al. , 1989 ). It takes ∼10 min to 
synthesize one CFTR molecule, and folding requires co- and post-
translational assembly events ( Du and Lukacs, 2009 ). CFTR folding 
involves formation of an intricate network of interdomain contacts 
between the N- and C-terminal membrane and cytosolic subdomains 
( Serohijos  et al. , 2008a ), and folding progresses through an ensemble 
of intermediates ( Lukacs  et al. , 1994 ;  Du  et al. , 2005 ). Consequently, 
CFTR folding is ineffi cient, with the majority of the newly synthesized 
protein partitioned toward a degradation pathway ( Cyr, 2005 ). 
 F508 is located in NBD1 and is not essential for Cl- conductance 
( Rowe  et al. , 2005 ), but its deletion leads pools of nascent 
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logical, except that the region in CFTR that is ubiquitinated by 
RMA1 is cytosolic. Therefore QC factors in addition to Derlin-1 may 
assist RMA1 in the selection of misfolded CFTR for ubiquitination. 
 Clues to the identity of such a factor come from the analysis of 
the Hsp40/DnaJ family of Hsc70 cochaperones ( Kampinga and 
Craig, 2010 ). Hsp40 proteins use a conserved J-domain to regulate 
Hsc70 ATPase activity and specify client proteins of Hsc70. One 
mechanism for specifi cation of Hsc70 function is for a specialized 
Hsp40 to attract Hsc70 to function in a discrete cellular location. 
Studies in yeast identify a unique Hsp40 subtype that is integrated 
into the ER membrane and exposes its J-domain to the cytosol 
( Walsh  et al. , 2004 ). This subfamily is represented in yeast by HLJ1 
(high copy lethal DnaJ 1), and deletion analysis suggests that HLJ1 
functions with cytosolic Hsc70 in ER QC ( Youker  et al. , 2004 ;  Han 
 et al. , 2007 ). RMA1 is not expressed in yeast, so we pondered 
whether an HLJ1-like protein might act with RMA1 in human cells to 
assist in the selection of CFTR for degradation. 
 Indeed, HLJ1-like Hsp40s are conserved in the human genome, 
and herein we report on the characterization of human DNAJB12 
(JB12). JB12 is a Type II Hsp40 that contains a J-domain and G/F-like 
region and is similar to HLJ1 in that it is localized to the ER mem-
brane and exposes its J-domain to the cytosol. JB12 differs from 
HLJ1, however, in that it contains N- and C-terminal extensions that 
were added during the course of evolution. Data presented demon-
strate that JB12 acts with Hsc70 and RMA1 to facilitate proteasomal 
degradation of CFTR and CFTRΔF508. JB12 forms complexes that 
contain RMA1 and Derlin-1, and increasing JB12 levels dramatically 
increases association of Hsc70 with ER-localized forms of CFTR and 
RMA1. Depletion of endogenous JB12 results in a signifi cant three-
fold increase in the folding effi ciency of CFTR and permits a pool of 
CFTRΔF508 to escape the ER. JB12 appears to direct Hsc70 to func-
tion with the E3 RMA1 in degradation of nascent CFTRΔF508 and 
CFTR. As fl uctuations in its activity have an impact on the fate of 
nascent CFTR, JB12 is capable of exerting control over the folding 
effi ciency of nascent polytopic membrane proteins. 
 RESULTS 
 JB12 is an ER-associated transmembrane Hsp40 
 JB12 (GI:294862531) is a 375-amino-acid protein that contains a J-
domain, a glycine/phenylalanine-rich region, and a single trans-
membrane domain ( Figure 1A ). The J-domain of JB12 is predicted 
to be located in the cytosol and is defi ned by the characteristic 
Hsc70 interaction sequence, HPD. The J-domain of JB12 is fl anked 
by a 112-residue N-terminal extension and a 111-amino-acid resi-
due C-terminal domain borders the transmembrane domain. The 
function of these respective domains in JB12 is unknown. Fluores-
cence microscopy of green fl uorescent protein (GFP)-JB12 demon-
strates that it colocalizes with the dye ER-tracker in a perinuclear 
location indicative of ER localization ( Figure 1B ). 
 In support of these data, JB12 cofractionates with the ER marker 
calnexin in HEK293 cells and behaves like an integral membrane 
protein in that it is not extracted from ER membrane with sodium 
carbonate ( Figure 1C ). Cytosolic Hsc70, but not the ER luminal pro-
tein BiP, is detected by Western blot in native JB12 immunoprecipi-
tates. This detection supports the prediction that its J-domain re-
sides in the cytosol ( Figure 1D ). The observed interaction of JB12 
with Hsc70 was dependent on JB12’s J-domain because JB12-QPD 
does not coprecipitate with  35 S-Hsc70 ( Figure 1E ). 
 JB12 can functionally interact with Hsc70 as a purifi ed JB12 frag-
ment (1–243), which contains the J-domain but lacks the transmem-
brane and ER luminal segments, stimulates Hsc70 ATPase activity 
from 5 to 15 nm ATP hydrolyzed · mg Hsc70 · min. This functional 
CFTRΔF508 to accumulate in a foldable, but kinetically trapped, 
conformation ( Denning  et al. , 1992 ;  Younger  et al. , 2004 ). CFTRΔF508 
misfolding appears to involve subtle defects in NBD1 folding 
( Thibodeau  et al. , 2005 ;  Serohijos  et al. , 2008a ) that cause cotrans-
lational misassembly of an intermediate that is degraded rapidly 
and may not accumulate ( Younger  et al. , 2006 ). Folding of the small 
pool of nascent CFTRΔF508 that is spared initial degradation is ar-
rested because of defective contact formation between NBD1 and 
regions that include intracellular loops exposed by MSD2 ( Serohijos 
 et al. , 2008a ) and misfolding of NBD2 ( Du  et al. , 2005 ). Conse-
quently, ∼99% of CFTRΔF508 is degraded prematurely by the ubiq-
uitin–proteasome system ( Jensen  et al. , 1995 ;  Ward  et al. , 1995 ). 
 CFTR folding is assisted by several different molecular chaper-
ones. The endoplasmic reticulum (ER)-associated Hsp40 Hdj-2 
(DNAJA1) helps attract cytosolic Hsc70 to the ER membrane surface 
to facilitate cotranslational folding and assembly of NBD1 ( Strickland 
 et al. , 1997 ;  Meacham  et al. , 1999 ). The ER luminal chaperone cal-
nexin appears to act after Hdj-2 to facilitate association of regions 
within the CFTR’s membrane-spanning and cytosolic domains ( Pind 
 et al. , 1994 ;  Rosser  et al. , 2008 ). Glycosylation of CFTR is required 
for calnexin binding, and this modifi cation appears to be required 
for stabilization of transmembrane regions in MSD2 in the ER mem-
brane ( Glozman  et al. , 2009 ). Terminal steps in folding of full-length 
CFTR are facilitated by Hsp90 and its associated cofactors ( Loo 
 et al. , 1998 ). Modulation of the Hsp90 cofactor AHA1 enhances 
CFTRΔF508 folding and is suffi cient to permit small pools of func-
tional CFTRΔF508 to accumulate at the cell surface ( Wang  et al. , 
2006 ). 
 Paradoxically, the selection of nascent forms of CFTR and 
CFTRΔF508 for proteasomal degradation is also facilitated by mo-
lecular chaperones. The cytosolic E3 ubiquitin ligase CHIP interacts 
with Hsc70 and/or Hsp70 to form a quality control (QC) machine 
that uses the polypeptide-binding activity of Hsc/Hsp70 to target 
misfolded CFTR for proteasomal degradation ( Meacham  et al. , 
2001 ). (From here on, Hsc70 and Hsp70 will be treated as the same 
protein and generally referred to as Hsc70.) In addition, the ER-as-
sociated E3 RMA1/RNF5 acts in association with Derlin-1 and the E2 
Ubc6e to ubiquitinate CFTR ( Younger  et al. , 2006 ). Ubiquitinated 
CFTR is delivered to the proteasome in a pathway that involves 
Gp78 ( Morito  et al. , 2008 ), BAP31 ( Wang  et al. , 2008 ), and p97 
( Dalal  et al. , 2004 ). How selection of CFTR for degradation by the 
RMA1 E3 machinery and CHIP E3 complex are synergized is not 
entirely clear. The RMA1 E3 complex, however, may act coincident 
with translation to recognize folding defects in CFTR that involve the 
misfolding and defective assembly of NBD1 into a complex with the 
R-domain ( Younger  et al. , 2006 ;  Rosser  et al. , 2008 ). In contrast, 
the CHIP E3 may act post-translationally to recognize misfolded 
regions of CFTR that include NBD2 ( Younger  et al. , 2006 ). 
 Deletion of F508 renders CFTR highly sensitive to changes in 
RMA1 activity, which suggests that the RMA1 E3 plays a critical role 
in selection of CFTRΔF508 for premature degradation ( Younger 
 et al. , 2006 ). It is unclear, however, how the RMA1 complex distin-
guishes between on- and off-pathway forms of nascent CFTR. RMA1 
interacts with the transmembrane QC factor Derlin-1, and small in-
terfering RNA (siRNA) knockdown (kd) of Derlin-1 enhances cell sur-
face expression of CFTR ( Sun  et al. , 2006 ;  Younger  et al. , 2006 ). 
Derlin-1 can form complexes with MSD1 of CFTR, and Derlin-1 over-
expression promotes ER retention and proteasomal degradation of 
CFTR ( Younger  et al. , 2006 ). Therefore it is possible that Derlin-1 is 
part of a complex that acts as a membrane chaperone to scan the 
assembly status of CFTR’s membrane regions and targets misas-
sembled forms to RMA1 for ubiquitination. This model seems 
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interaction is J-domain dependent as rates of ATP hydrolysis by 
Hsc70 in the presence of JB12-QPD 1–243 do not increase (unpub-
lished data ). Purifi ed JB12 1–243 also cooperates with purifi ed 
Hsc70 to suppress the aggregation of thermally denatured luciferase 
( Figure 1F ). JB12 lacks conserved regions in Hsp40s known to bind 
soluble non-native polypeptides ( Fan  et al. , 2004 ). This appears to 
explain why JB12 was incapable of acting independently to sup-
press luciferase aggregation ( Figure 1F ). Lack of intrinsic chaperone 
activity toward water-soluble proteins may also explain why JB12 
1–243 is unable to act like the Type I Hsp40 Ydj1 and cooperate with 
Hsc70 to refold denatured luciferase ( Figure 1G ). These collective 
data indicate that JB12 is an ER-localized Hsp40 that uses its 
J-domain to regulate Hsc70s ATPase activity and enhance Hsc70 
chaperone activity. 
 JB12 mediates proteasome-dependent CFTR degradation 
 Due to JB12’s localization to the ER, we investigated whether 
JB12 interacts with Hsc70 to facilitate CFTR and CFTRΔF508 
folding and/or degradation. Increasing JB12 levels prevented 
accumulation of the ER-localized B-form and the maturely glyco-
sylated and plasma membrane–localized C-form of CFTR 
( Figure 2A ). Elevation of JB12 also caused similar decreases in 
the accumulation of the B-form of CFTRΔF508. Overexpressed 
JB12-QPD only moderately decreased CFTR folding and 
CFTRΔF508 accumulation, suggesting that JB12’s action appears 
to require Hsc70. Structure function analysis shows that JB12 re-
quires association with the ER membrane to impact CFTR levels 
because deletion of its transmembrane domain rendered it inac-
tive ( Figure 2B ). The N- and C-terminal domains of JB12 that 
fl ank the J-domain and transmembrane region, however, are not 
required for overexpressed JB12 to partition CFTR out of its fold-
ing pathway ( Figure 2B ). The results are evident when comparing 
CFTR levels under conditions where JB12 1–243, JB12 1–264, 
and JB12 112–375 are overexpressed to similar levels as full-
length JB12 ( Figure 2B ). Thus overexpressed JB12 uses its J-
domain and transmembrane domain to decrease the accumula-
tion of CFTRΔF508 and CFTR. 
 The reduction of total CFTR accumulation resulting from JB12 
overexpression is proteasome dependent as it is blocked by 
the proteasome inhibitor bortezomib ( Figure 2C ). When JB12 is 
 FIGURE 1:  JB12 is an ER-associated transmembrane Hsp40. (A) JB12 
is predicted to contain an N-terminal J-domain, a glycine/
phenylalanine (G/F)-rich region, and a transmembrane (TM) domain. 
The J-domain of JB12 contains the characteristic Hsc70 interaction 
sequence, HPD. (B) Localization of GFP-JB12 with the ER in 
transiently transfected HEK293 cells by fl uorescence microscopy. 
HEK293 cells transfected with 100 ng of pcDNA3.1(+)-GFP-JB12 were 
stained with ER-Tracker dye to visualize the localization of ER relative 
to that of GFP-JB12. (C) Fractionation of HA-JB12 with membranes 
that contain the ER marker calnexin. Membrane fractions isolated 
from HEK293 cells that were transfected with 0.05 µg of 
pcDNA3.1(+)-HA-JB12 were split into equal amount fractions and 
subjected to washes with 1.0 M NaCl, 0.1 M sodium carbonate, or 
1.0% Triton. Membranes were then reisolated for each sample; S and 
P denote the supernatant and pellets of the centrifuged samples. The 
total (T) sample is the soluble fraction from a low-speed spin early in 
the fractionation process and is used to compare to levels of JB12 in 
the wash steps. The sodium carbonate data were performed as a 
separate experiment and are shown separately from the other 
samples. (D) Association of JB12 with Hsc70, but not BiP. HA-JB12 
was immunoprecipitated from soluble cell lysates prepared with 
PBS-Triton (1%) and the cytosolic Hsc70, but not the ER-resident 
Hsc70 BiP, was found to exist in the isolated JB12-containing 
complexes. (E) HPD-dependent co-IP of endogenous Hsc70 with 
JB12-myc. JB12-myc or JB12-QPD-myc was immunoprecipitated from 
 35 S-labeled cell extracts prepared with PBS-Triton (1%). 
(F) Cooperation of JB12 1–243 with Hsc70 in suppression of heat-
denatured luciferase (LUC). Reactions were heated at 42ºC for 10 min 
followed by centrifugation to isolate the supernatant (S) and pellet (P) 
fractions from the total (T) sample. (G) Purifi ed JB12 1–243 is unable 
to cooperate with Hsc70 to refold denatured luciferase. Luciferase 
was denatured in 6 M guanidinium HCl and then diluted into samples 
containing the indicated purifi ed protein combinations. The folding 
reactions were incubated for 1 h at 25ºC, and luciferase activity was 
measured on a Turner luminometer. The amount of luciferase activity 
for each sample was normalized to the control sample, Hsc70 + Ydj1. 
The bar graph represents the average values obtained from two 
independent experiments. 
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 When the ER-associated protein degra-
dation (ERAD) pathway was inhibited by 
overexpression of a dominant negative form 
of the ER retrotranslocation factor p97 
(p97QQ), inhibition of JB12-dependent 
degradation of CFTR and CFTRΔF508 was 
also observed ( Figure 2D ). In addition, the 
degradation intermediates of the B-form of 
CFTR and CFTRΔF508 that p97QQ drove to 
accumulate were demonstrated via immu-
noprecipitation (IP) and Western blot analy-
sis to be ubiquitinated. p97QQ is a domi-
nant negative form of p97 that binds (but 
cannot release) substrates, and blocks ex-
traction of ubiquitinated proteins from the 
ER ( Hirsch  et al. , 2009 ). Yet p97 is an abun-
dant protein, so its function in CFTR degra-
dation was not blocked completely by 
p97QQ overexpression, and p97QQ was 
not as effective as bortezomib in blocking 
JB12-dependent CFTR degradation. 
 In the presence of p97QQ and JB12, lev-
els of CFTRΔF508 were not restored to 
those observed in the absence of JB12. In 
contrast, when bortezomib was used to in-
hibit the proteasome in the presence of 
JB12, CFTRΔF508 levels were dramatically 
increased and levels of CFTRΔF508 were 
similar to those detected in bortezomib-
treated cells in which JB12 was not elevated 
( Figure 2C ). Therefore proper function of 
p97 may be required to stabilize the B-form 
of CFTRΔF508 during the process of JB12-
dependent proteasomal degradation, but 
this hypothesis remains to be tested. 
 Knockdown of endogenous JB12 
increases CFTR folding effi ciency 
 To evaluate the role of endogenous JB12 in 
CFTR biogenesis, siRNA experiments were 
performed and the effect that kd of JB12 
had on biosynthetic maturation of CFTR 
and CFTRΔF508 in HEK293 cells was evalu-
ated by pulse-chase and Western blot anal-
ysis ( Figure 3, A and B ). Endogenous JB12 
levels were reduced by >90% in HEK293 
cells, and the pair of siRNAs used were spe-
cifi c in that the individual siRNAs were both 
capable of independently performing this 
task (unpublished data ). JB12 kd also had 
no detectable impact on the levels of other 
QC factors that modulate CFTR folding or 
degradation (Supplemental Figure S1). Data 
from pulse-chase studies show that reduc-
tion in JB12 levels leads to a dramatic three-
fold increase in the quantity of nascent 
B-form CFTR that is converted to the C-form by the end of the 
pulse-chase time course. Likewise, the half-life of CFTRΔF508 was 
increased upon JB12 kd, but accumulation of its folded C-form was 
not detected. 
 When steady-state levels of CFTR were assayed 72 h after 
JB12 kd, severalfold more of the C-form accumulated, and this 
overexpressed and the proteasome is inhibited, severalfold more of 
the B-form of CFTR and CFTRΔF508 accumulates and a portion of 
the B-form migrates on gels as a low-mobility smear reminiscent 
of a polyubiquitinated species. Thus JB12 appears to reduce accu-
mulation of the C-form of CFTR and the B-form of CFTRΔF508 via 
a proteasome-dependent pathway. 
 FIGURE 2:  JB12 mediates proteasome-dependent CFTR degradation. (A) JB12 overexpression 
decreases CFTR accumulation as detected by Western blots of HEK293 cell extracts that were 
transiently transfected with indicated combinations of expression plasmids for CFTR, 
CFTRΔF508, JB12-myc, or JB12-QPD-myc. (B) JB12-mediated degradation of CFTR requires the 
transmembrane domain but not the N- or C-terminal extensions. HEK293 cells transiently 
transfected with pcDNA3.1(+)-CFTR (1 µg) and increasing amounts of pcDNA3.1(+)-JB12-myc or 
pcDNA3.1(+)-JB12-myc truncation mutants (which ranged from 5 to 75 ng) were isolated and 
subjected to Western blot analysis with the indicated antibodies. (C) JB12-mediated decrease in 
CFTR accumulation is sensitive to the proteasome inhibitor bortezomib (10 µM) that was added 
4 h prior to analyzing the samples by Western blot. (D) Ubiquitinated forms of CFTR and 
CFTRΔF508 accumulate when their JB12-stimulated degradation is hindered via expression of a 
dominant negative form of p97, p97QQ. CFTR or CFTRΔF508 was immunoprecipitated from 
extracts of cells that express the indicated proteins. Ubiquitinated CFTR or CFTR in 
immunoprecipitated material was detected by Western blot. When p97QQ interfered with the 
ERAD pathway and JB12 was overexpressed, the level of ubiquitinated CFTR detected was 92% 
of the quantity that accumulated when only p97QQ was expressed. Levels of ubiquitinated 
CFTRΔF508 in the presence of JB12 and p97QQ were 45% of levels detected when only p97QQ 
was expressed, and this value refl ected the relative level of CFTRΔF508 under the indicated 
experimental condition. (See Results for an explanation.) Where indicated, bands B and C 
represent the immaturely glycosylated and maturely glycosylated forms of CFTR, respectively. 
Loading consistency is indicated relative to levels of tubulin in different panels. 
Volume 22 February 1, 2011 Triage of CFTR by DNAJB12 | 305 
accumulation appeared to be due to increased folding effi ciency 
as it was not accompanied by a corresponding increase in the 
B-form levels. We could also see an increase in the accumulation 
of the B-form of CFTRΔF508, but the effects of JB12 kd on 
CFTRΔF508 were less dramatic than those of CFTR. 
 To demonstrate that the function of JB12 in CFTR biogenesis in 
HEK293 cells is relevant to what occurs in lung epithelial cells, the 
impact of JB12 kd on CFTR and CFTRΔF508 biogenesis in immortal-
ized human bronchial epithelial (CFBE) cells was determined 
( Figure 3C ). JB12 levels could be reduced by >70% in CFBE cells, 
and this reduction was accompanied by a severalfold increase in 
accumulation of the C-form of CFTR. Again, we also observed JB12 
kd to permit increased accumulation of the B-form of CFTRΔF508, 
but the C-form was diffi cult to detect. 
 Changes in JB12 levels correlate inversely with CFTR and 
CFTRΔF508 levels in both HEK293 and CFBE cells. CFTR folding is 
dramatically increased by JB12 kd, but increases in folded 
CFTRΔF508 are less dramatic. Thus JB12 action appears to limit 
CFTR folding effi ciency, whereas other cellular factors or kinetic 
folding defects limit the folding of CFTRΔF508. The effect of 
CFTRΔF508 behavior upon JB12 kd fi ts with the concept that the 
majority of CFTRΔF508 accumulates in a kinetically trapped non-
native state that is diffi cult to bring back onto a folding pathway 
( Younger  et al. , 2004 ). 
 Knockdown of JB12 and Hdj-2 have opposite effects on 
CFTR folding 
 JB12 and the cytosolic Type I Hsp40 Hdj-2 ( Meacham  et al. ,  1999 ) 
both act on the cytoplasmic face of the ER but appear to differen-
tially direct Hsc70 to promote the life or death of CFTR. If this inter-
pretation is true, then Hdj-2 kd should hinder CFTR folding and 
accelerate degradation of the B-form of CFTR and CFTRΔF508. To 
test this supposition, Hdj-2 levels were reduced by small hairpin 
RNA (shRNA) and the impact that this reduction had on CFTR levels 
was determined. Hdj-2 is highly abundant, but shRNAs were able to 
reduce its levels by ∼70%, which was associated with a 70% reduc-
tion in accumulation of the folded C-form of CFTR and a 50% reduc-
tion in accumulation of the immature B-form of CFTRΔF508 
( Figure 4A ). Data from pulse-chase studies suggest that decreased 
accumulation of folded CFTR detected by Western blot when Hdj-2 
levels are low results from decreased folding and stability of the 
nascent B-form ( Figure 4B ). Hdj-2 kd decreased CFTR folding effi -
ciency severalfold and decreased stability of the nascent B-form of 
CFTRΔF508. These data support the notion that Hdj-2 and JB12 
direct Hsc70 to play opposing roles in CFTR folding and degrada-
tion, respectively. 
 Modulating JB12 levels does not appear to cause gross changes 
in ER protein QC activity in HEK293 cells because JB12 kd does not 
impact degradation of two different topologically distinct ERAD 
substrates ( Figure 4, C and D ). TCRα is a subunit of the T-cell recep-
tor, has a large luminal domain and single transmembrane domain, 
and is degraded rapidly via ERAD when expressed alone because it 
lacks assembly partners ( Tiwari and Weissman, 2001 ). ApoB48 is in-
serted across the ER membrane and is an Hsc70 client but is de-
graded rapidly in HEK293 cells because they don’t express special-
ized folding factors required for proper biogenesis ( Fisher  et al. , 
1997 ). JB12 kd does not alter the steady-state levels of TCRα or 
ApoB48 ( Figure 4C ), and pulse-chase studies show that JB12 kd 
does not alter the biosynthesis or half-life of either ( Figure 4D ). Thus 
stabilization of the B-form of CFTR upon JB12 kd is not associated 
with a general stabilization of other ERAD substrates that have 
different domain structures. 
 FIGURE 3:  Knockdown of endogenous JB12 increases CFTR folding 
effi ciency. Pulse chase (A) and Western blot (B) analyses indicate that 
the folding effi ciency of CFTR is dramatically enhanced whereas the 
stability of CFTRΔF508 is modestly increased in JB12 siRNA HEK293 
cells. The folding effi ciency of CFTR increases from approximately 
15 ± 2% to 45 ± 3% of the B-form at t = 0 upon kd of JB12 (n = 3). 
Under control conditions (si-Cont), the half-life of CFTRΔF508 was 
40 min (SD ± 2 min) and in the absence of JB12 increased 1.5-fold to 
60 min (SD ± 2 min; n = 3). The band marked with an * is a background 
band in the IP reactions in (B). (C) JB12 kd in human CFBE cells also 
increases accumulation of CFTR and CFTRΔF508. The immaturely 
glycosylated B-form and maturely glycosylated C-form of CFTR are 
indicated. Results were quantifi ed by densitometry and were either 
normalized to the relative amount of CFTR B-band at t = 0 for each 
condition (A) or the CFTR B- and C-band levels were normalized to 
the si-Cont reactions (B and C). 
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absence of overexpressed JB12. The Hsc70 present with CFTRΔF508 
in initial precipitates was determined by reimmunoprecipitation (re-
IP). The quantity of  35 S-Hsc70 coprecipitated with CFTRΔF508 when 
ATP levels were elevated was low, but an increase was detected 
upon expression of HA-JB12. This fi nding is impressive as the quan-
tity of CFTRΔF508 in cells was signifi cantly lower when JB12 was 
elevated. Depletion of ATP resulted in a more dramatic, approxi-
mately 10-fold increase in JB12-dependent Hsc70 binding to the 
B-form of CFTRΔF508 ( Figure 5B , bottom panel). HA-JB12-QPD ex-
pression had little impact on accumulation of the B-form of 
CFTRΔF508 and did not cause an increase in Hsc70 binding to 
CFTRΔF508. Similar results were observed with the B-form of CFTR 
(unpublished data ). These data indicate that JB12 acts in an ATP- 
and J-domain–dependent manner to increase association of Hsc70 
with complexes that contain the nascent B-form of CFTR. 
 JB12 is present in complexes that contain RMA1 and can in-
crease Hsc70 binding to the B-form of CFTR and CFTRΔF508. Thus 
JB12 appears to act with RMA1 in degradation of the misfolded B-
form of CFTR and CFTRΔF508. If so, JB12 should be present in 
complexes that contain CFTRΔF508 as well as RMA1, Hsc70, and 
Derlin-1 ( Younger  et al. , 2006 ). This supposition was tested in  35 S-
labeled cells that expressed HA-JB12, fl ag-RMA1, Derlin-1, and 
CFTRΔF508 and that were lysed under native conditions ( Figure 
5C ). HA-JB12 was immunoprecipitated, and the ERQC factors of 
interest were identifi ed by re-IP. A large number of radiolabeled pro-
teins the sizes of which spanned the range of molecular weights re-
solved on a 12.5% gel were found to coprecipitate HA-JB12 but not 
with the beads used in precipitations. The large number of bands 
associated with JB12 is consistent with it functioning with Hsc70 to 
facilitate the biogenesis of a range of substrates. Re-IPs identifi ed 
Hsc70, RMA1, Derlin-1, and CFTRΔF508 in precipitates with JB12 
( Figure 5C ). We performed similar experiments with CHIP-myc 
but never detected the overexpressed or endogenous CHIP in a 
complex with JB12 (unpublished data ). 
 Of note is that in each of the re-IPs with the indicated antibodies 
a quantity of JB12 was present. The proteins of interest are mem-
brane proteins that aggregate at elevated temperatures, so samples 
were heated at 55ºC, instead of 100ºC, before the re-IP step to 
disrupt interactions between JB12 and the antibody used for initial 
precipitations. In the absence of boiling, however, this process is 
incomplete; thus JB12 is present in the Hsc70, RMA1, and Derlin-1 
re-IPs. To complicate things further, CFTRΔF508 can aggregate 
when heated >37ºC in an SDS sample buffer, so the samples used 
for re-IPs of CFTR were incubated at 37ºC instead of 55ºC. There-
fore the original antibody–JB12 interactions were not disrupted, 
and we observed more JB12 in the CFTRΔF508 re-IPs than in other 
re-IPs. Controls demonstrate, however, that the presence of Hsc70, 
RMA1, Derlin-1, and CFTRΔF508 in re-IPs occurs only if antibodies 
specifi c to these individual proteins are present. 
 Derlin-1 interacts with multiple E3 ubiquitin ligases ( Hirsch  et al. , 
2009 ), and yeast JB12 is found to cooperate with Hsc70 Ssa1 and 
the ER-associated E3 Doa10 in the degradation of P-type ATPases 
and other model ERAD substrates ( Han  et al. , 2007 ;  Nakatsukasa 
 et al. , 2008 ). Thus we explored the specifi city of interactions be-
tween JB12 with Derlin-1 and RMA1 via determination of whether 
JB12 could coprecipitate in complexes with the following ER-
localized E3 ubiquitin ligases: Gp78 ( Morito  et al. , 2008 ), March V 
( Bartee  et al. , 2004 ), HRD1 ( Hirsch  et al. , 2009 ), and SEL1 ( Hirsch 
 et al. , 2009 ) (Supplemental Figure S2). Association of JB12 with 
Gp78, a known interaction partner of RMA1, was detected ( Morito 
 et al. , 2008 ), but complexes with MarchV, HRD1, or SEL1 were not 
observed. These data suggest that JB12 selectively interacts with a 
 FIGURE 4:  Knockdown of JB12 and Hdj-2 has opposite effects on 
CFTR folding. (A and B) Hdj-2 kd decreases folding and stability of 
CFTR. Hdj-2 shRNA (sh-Hdj2) or cont-shRNA (sh-Cont) HEK293 cells 
transfected with pcDNA3.1(+)-CFTR or pcDNA3.1(+)-CFTRΔF508 were 
collected for Western blot analysis of CFTR steady-state levels (A) or 
 35 S-labeled for CFTR pulse-chase analysis (B). The steady-state levels 
(C) and half-life (D) of either ApoB or TCRα are not affected by JB12 
siRNA (si-JB12). Results that were quantifi ed by densitometry were 
either normalized to the control reactions (A and C) or normalized to 
the relative amount of  35 S-labeled material at t = 0 for each condition 
(B and D). 
 JB12 drives Hsc70 to associate with CFTR and the 
RMA1 E3 complex 
 To explore the mechanism for JB12 action, its presence in com-
plexes that contain RMA1 and/or CHIP was explored ( Figure 5A ). 
Protein–protein interactions were evaluated by asking whether JB12 
and Hsc70 coprecipitate under native buffer conditions with either 
RMA1 or CHIP. JB12 and Hsc70 were pulled down with RMA1, but 
CHIP was not detected in complexes with JB12. In addition, eleva-
tion of JB12 levels increased the quantity of Hsc70 that coprecipi-
tated with fl ag-RMA1 ( Figure 5A ). 
 Next we evaluated the impact that elevation of JB12 levels had 
on Hsc70 binding to nascent  35 S-CFTRΔF508 ( Figure 5B ). CFTRΔF508 
was immunoprecipitated from native cell extracts in the presence or 
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subset of ER-associated E3 ligases (Supplemental Figure S2). Over-
all, data obtained on protein–protein interactions with JB12 demon-
strate that it selectively associates with components of the RMA1 E3 
complex and can facilitate the association of Hsc70 with nascent 
CFTR/CFTRΔF508 and RMA1. 
 RMA1 is required for JB12 to promote CFTR degradation 
 On the basis of data presented thus far ( Figure 5 ), we suggest that 
JB12 functionally interacts with RMA1, but not CHIP, in degradation 
of misfolded forms of CFTR. This interpretation is based on the pres-
ence of JB12 in complexes with RMA1, Derlin-1, Hsc70, and CFTR 
and an inability to detect JB12 in complexes that contain Hsc70 and 
CHIP. If this is true, then RMA1, but not CHIP, should be required for 
JB12-dependent partitioning of nascent CFTR out of its folding 
pathway. To further evaluate the potential for functional interactions 
between CHIP and RMA1, we compared the impact of elevating 
JB12 approximately onefold over endogenous pools on CFTR 
biogenesis when either RMA1 or CHIP levels were depleted 
( Figure 6A ). In cells treated with a control siRNA, elevation of JB12 
reduced accumulation of the B- and C-forms of CFTR to a barely 
detectable level ( Figure 6A ). As predicted, kd of RMA1 hindered the 
ability of overexpressed JB12 to promote CFTR degradation. It is 
important to note, however, that in the absence of RMA1, JB12 still 
retained CFTR in the ER ( Figure 6A , top panel). Similarly, when 
RMA1 is knocked down, overexpressed JB12 did not decrease the 
accumulation of CFTRΔF508 ( Figure 6A, bottom panel). In contrast, 
JB12 was still fully capable of promoting degradation of CFTR and 
CFTRΔF508 when CHIP was depleted ( Figure 6A ). 
 Further support for the concept of functional interaction be-
tween JB12 and RMA1 in CFTR degradation comes from the ob-
servation that these proteins can synergize to perform this function 
( Figure 6B ). Coexpressing JB12-myc and fl ag-RMA1 at levels 
where individually they have a modest effect on steady-state levels 
of CFTR ( Figure 6B , top panel) or CFTRΔF508 ( Figure 6B , bottom 
panel) leads to dramatic decreases in the folded C-form of CFTR 
and the B-form of CFTRΔF508. The decrease observed is blocked 
via treatment of cells with the proteasome inhibitor bortezomib, 
suggesting that JB12 and RMA1 cooperate in targeting CFTR for 
proteasomal degradation. The collective data from siRNA and 
overexpression studies, when combined with data from co-IP ex-
periments, suggest that JB12 cooperates with Hsc70 to mediate 
RMA1-dependent CFTR degradation. 
 JB12 monitors the folding status of CFTR N-terminal 
regions 
 Chaperone-dependent steps in CFTR folding and degradation have 
been uncovered via analysis of the assembly of CFTR N- and C-
terminal fragments (CFTR 837X and CFTR 837–1480) into a com-
plex that escapes the ER and functions as a Cl- channel ( Chan  et al. , 
2000 ). Studies with CFTR 837X suggest that deletion of F508 causes 
a severe defect in formation of a folding intermediate that contains 
MSD1, NBD1, and the R-domain that is critical for the folding pro-
gression of CFTR ( Rosser  et al. , 2008 ). Recognition of folding defects 
in amino-terminal regions of CFTRΔF508 by the RMA1 E3 complex 
is proposed to be a major cause of premature CFTR degradation 
( Younger  et al. , 2006 ;  Rosser  et al. , 2008 ). Thus we sought to obtain 
support for the conclusion that JB12 participates with RMA1 and 
 FIGURE 5:  JB12 drives Hsc70 to associate with CFTR and the RMA1 
E3 complex. (A) JB12 and Hsc70 coprecipitate with the RMA1 E3 
ligase, but the E3 ligase CHIP was not observed in a complex with 
JB12. Flag-RMA1 was immunoprecipitated from soluble cell lysates 
prepared with PBS-Triton (1%), and both Hsc70 and JB12-myc were 
found in association with RMA1-containing complexes. In contrast, IP 
of HA-JB12 from soluble cell lysates isolated Hsc70, but not CHIP-
myc, in JB12-containing complexes. The presence of indicated 
proteins in native immunoprecipitates was determined by Western 
blot. (B) Elevation of JB12 increases the quantity of  35 S-Hsc70 that 
associates with CFTRΔF508 in a nucleotide-dependent manner. HEK 
293 cells transfected with pcDNA3.1(+)-CFTRΔF508 and pcDNA3.1(+)-
JB12-myc or pcDNA3.1(+)-JB12-QPD-myc, as indicated, were labeled 
with  35 S-methinone, and co- and re-IP reactions were conducted as 
described in Materials and Methods. Briefl y, the samples were lysed in 
PBS-Triton (1%) with either an ATP regeneration system (+ ATP) or 
with apyrase (− ATP), and CFTR was immunoprecipitated from the 
soluble cell lysates. The reactions were then subjected to a secondary 
re-IP with α-Hsc70 antibody. Western blots indicate the levels of 
CFTRΔF508 when JB12 or JB12-QPD is overexpressed. (C) Hsc70, 
fl ag-RMA1, Derlin-1, and CFTRΔF508 coprecipitate with HA-JB12. 
HEK 293 cells overexpressing HA-JB12, fl ag-RMA1, Derlin-1, and 
CFTRΔF508 were labeled with  35 S-methinone and solubilized with 
PBS-Triton (1%). Co-IP and re-IP reactions were conducted as 
described in Materials and Methods. In general, HA-JB12 was isolated 
from the cell lysates, and secondary re-IP steps identifi ed fl ag-RMA1, 
Derlin-1, endogenous Hsc70, and CFTRΔF508 as being part of a 
JB12-containing complex. A 3-d fi lm exposure was suffi cient to 
visualize proteins bound in initial co-IP reactions (C), whereas a 
7-d exposure was necessary to visualize bands in the 
reimmunoprecipitated samples (B and C). 
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Derlin-1 in selecting CFTR for degradation by asking if JB12 associ-
ates with CFTR 837X and determining whether it facilitates CFTR 
837X degradation ( Figure 7 ). 
 To analyze the association between JB12 and CFTR 837X, 
HEK293 cells were transfected with either CFTR 837X (which is com-
posed of MSD1, NBD1, and the R-domain) or the MSD2- and NBD2-
containing C-terminal CFTR fragment 837–1480. Endogenous JB12 
was then immunoprecipitated and via Western blot was found to 
coprecipitate with CFTR 837X ( Figure 7A ). This complex appears to 
be a result of a specifi c interaction, as a complex that contains en-
dogenous JB12 and CFTR 837–1480 was not isolated. Similar re-
sults were obtained with CFTR 837XΔF508 (unpublished data ). Thus 
endogenous JB12 associates with an amino-terminal region of 
CFTR, the conformation of which is surveyed by components of 
the RMA1 E3 complex. 
 Deletion of F508 hinders the folding of CFTR 837X, and this frag-
ment is unstable ( Rosser  et al. , 2008 ). Knockdown of JB12 or RMA1 
results in a two- to threefold increase in the accumulation of CFTR 
837XΔF508 with the greatest effect observed upon JB12 kd ( Figure 7B ). 
This increase in accumulation is related to recognition of misfolded 
CFTR 837XΔF508 by RMA1 and JB12 as accumulation of CFTR 837X, 
which is highly stable ( Meacham  et al. , 1999 ), was only modestly in-
creased upon kd of JB12 or RMA1. Furthermore, accumulation of the 
C-terminal CFTR 837–1480 fragment is not affected by kd of JB12 
( Figure 7C ). We do observe, however, that the levels of CFTR 837–
1480 increase in the absence of RMA1 ( Figure 7D ). Thus RMA1 may 
also have additional functions that are independent of JB12. 
 CFTR 837X, but not CFTR 837XΔF508, assembles into a com-
plex with CFTR 837–1480 that escapes the ER as indicated by its 
accumulation as a glycosylated species that is resistant to Endo H 
treatment ( Rosser  et al. , 2008 ). Intriguingly, productive interactions 
between the two halves of CFTR when JB12 ( Figure 7C ) or RMA1 
( Figure 7D ) levels are knocked down are enhanced such that signifi -
cantly more folded, maturely glycosylated CFTR 837–1480 accumu-
lates. Thus JB12 or RMA1 kd allows for the increased association 
and proper assembly of N- and C-terminal regions of CFTR. Kd of 
these ERQC factors, however, does not permit CFTR 837XΔF508 
and CFTR 837–1480 to assemble into a complex that escapes the 
ER as indicated by the lack of CFTR 837–1480 accumulation as a 
maturely glycosylated species ( Figure 7, C and D ). Thus JB12 can 
act at an early stage of CFTR biogenesis, which is coincident with 
RMA1 action, to modulate the assembly of N- and C-terminal CFTR 
fragments into a complex that can escape the ER. 
 Stepwise correction of CFTRΔF508 folding to wild-type 
levels through depletion of JB12 and intragenic suppression 
of intrinsic folding defects 
 The contribution that ERQC activities versus intrinsic folding kinetics 
play in governing membrane protein folding is unclear, and this in-
formation is required to develop approaches to correct CFTRΔF508 
misfolding. Therefore we investigated the relative contribution that 
folding kinetics and the basal ERQC activity contribute to premature 
CFTRΔF508 degradation. SiRNA kd of JB12 can increase CFTR fold-
ing effi ciency threefold, whereas elevation of JB12 limits the folding 
progression of CFTR ( Figures 2 and  3 ). In contrast, siRNA kd of JB12 
permits only a small quantity of CFTRΔF508 to accumulate in the 
folded C-form ( Figure 3 ) and does not enhance assembly of CFTR 
837XΔF508 into a folded channel ( Figure 7, C and D ). Thus folding 
of CFTR and CFTRΔF508 appear to differ in that ERQC activity limits 
effi ciency of CFTR folding, whereas some other unknown ERQC 
factor and/or intrinsic folding defects caused by deletion of F508 
limits CFTRΔF508. 
 FIGURE 6:  RMA1 is required for JB12 to promote CFTR degradation. 
(A) The effect that RMA1 or CHIP kd has on JB12-dependent 
decreases in CFTR and CFTRΔF508 accumulation as detected by 
Western blot. Antibodies directed against RMA1 and CHIP were used 
to detect the extent of kd of endogenous RMA1 and CHIP levels. 
(B) Impact of RMA1 and JB12 action alone and in combination on 
accumulation of CFTR and CFTRΔF508 levels. RMA1 and JB12 blots 
are included to show the level of overexpression of these proteins 
relative to their endogenous levels. Tubulin blots indicate loading 
consistency. 
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from not being detectable to 0.08 ( Fig-
ure 8A ). CFTRΔF508 folding is improved to 
a point at which the C/B ratio is further in-
creased to ∼0.2 when JB12 is depleted and 
Corr-4a is present. Folding of CFTRΔF508 
increased dramatically upon introduction of 
the V510D suppressor mutation because 
CFTRΔF508 V510D accumulated at a C/B 
ratio of 0.2. Strikingly, depletion of JB12 in-
creased the C/B ratio of CFTRΔF508 V510D 
more than eightfold to an impressive value 
near 1.6, which is 50% of the ratio observed 
for wild-type CFTR. In pulse-chase experi-
ments, we also observed depletion of JB12 
to permit CFTRΔF508 V510D to fold with 
∼50% of wild-type effi ciency ( Figure 8B ). 
 The combination of JB12 kd and Corr-4a 
treatment enabled CFTRΔF508 V510D to 
obtain a C/B ratio of 3.5, which is the same 
as the 3.4 value observed with wild-type 
CFTR. In pulse-chase experiments, we also 
observed that these conditions permit the 
B-form of CFTRΔF508 V510D to convert to 
the C-form with an effi ciency that was 
greater than CFTR ( Figure 8B ). Corr-4a is 
able to stabilize transmembrane regions of 
CFTR ( Wang  et al. , 2007 ;  Grove  et al. , 2009 ), 
which may explain the twofold increase in 
CFTRΔF508 V510D folding effi ciency that 
occurs when Corr-4a is present in JB12-
depleted cells. When JB12 activity is atten-
uated and intrinsic folding defects are cor-
rected, CFTRΔF508 can fold and escape 
the ER at levels similar to wild-type CFTR. 
Thus it appears that activity of JB12 and in-
trinsic folding kinetics both play important 
roles in limiting the escape of CFTRΔF508 
from the ER. 
 DISCUSSION 
 JB12 is identifi ed as an ER-associated 
Hsp40 with a cytosolic J-domain that func-
tions with Hsc70 and the RMA1 E3 ligase complex to mediate pro-
teasomal degradation of CFTR and CFTRΔF508. JB12 exerts control 
over the fate of nascent CFTR and possibly other polytopic proteins 
because modulation of its activity within a narrow range has dra-
matic positive and negative effects on CFTR folding effi ciency. JB12 
exhibits characteristics of a rheostat that helps control the fate of 
nascent CFTR and CFTRΔF508 by impacting the partitioning of na-
scent forms between life and death. 
 JB12 depletion strongly increased CFTR folding effi ciency but 
has modest positive effects on CFTRΔF508 folding. These data are 
consistent with the concept that the folding pathways of CFTR and 
CFTRΔF508 have different rate-limiting steps ( Lukacs  et al. , 1994 ; 
 Thibodeau  et al. , 2005 ;  Serohijos  et al. , 2008b ). A major obstacle 
that limits folding of nascent CFTR appears to be basal activity of 
ERQC factors, such as JB12 and other components of the RMA1 E3 
ubiquitin ligase complex ( Grove  et al. , 2009 ). In contrast, the major 
limiting factor for CFTRΔF508 folding are defects in NBD1 folding/
assembly that lead it to accumulate in a kinetically trapped state 
( Younger  et al. , 2004 ;  Aleksandrov  et al. , 2010 ;  Wang  et al. , 2010 ). 
One such folding defect is proposed to be related to defective 
 To explore this issue, we evaluated the relative contribution of 
JB12 action and defective folding kinetics on escape of CFTRΔF508 
from the ER. We compared the extent to which the introduction of 
V510D, a misfolding suppressor mutation, into CFTRΔF508 versus 
inactivation of JB12 enhanced CFTRΔF508 folding ( Figure 8 ). Resi-
due V510 is located near F508 on the surface of NBD1, and its mu-
tation to an Asp helps to increase cell surface expression of 
CFTRΔF508 by a mechanism that is proposed to involve enhance-
ment of interdomain contacts ( Mornon  et al. , 2008 ). The folding of 
CFTR, CFTRΔF508, and CFTRΔF508 V510D was compared under 
control conditions, upon JB12 depletion, when cells were treated 
with the folding corrector Corr-4a ( Pedemonte  et al. , 2005 ), or with 
a combination of the above conditions. CFTR folding effi ciency was 
evaluated in Western blots by measuring the ratio of the C-band 
and B-band that accumulated ( Figure 8A ). In parallel, we carried out 
pulse-chase studies and compared the effi ciency of B-band conver-
sion to C-band at different chase times ( Figure 8B ). Data obtained 
from both sets of experiments are mutually supportive. 
 JB12 siRNA permits approximately fourfold more CFTRΔF508 to 
accumulate in the C-form, and the ratio of the C- to B-form increased 
 FIGURE 7:  JB12 monitors the folding status of CFTR N-terminal regions. (A) Endogenous JB12 
interacts with the N-terminal half of CFTR. HEK293 cells transfected with either pcDNA3.1(+)-
CFTR 837X or pcDNA3.1(+)-CFTR 837–1480 were lysed with PBS-Triton (1%), and endogenous 
JB12 was immunoprecipitated. Western blots of precipitates were probed with either α-CFTR 
N-terminal tail or α-CFTR-NBD2. (B–D) Transfections with JB12 or RMA1 siRNA oligos and 
pcDNA3.1(+)-CFTR 837X, pcDNA3.1(+)-CFTR 837XΔF508, or pcDNA3.1(+)-CFTR 837–1480 were 
performed as described in Materials and Methods. Levels of indicated proteins in cell extracts 
were determined by Western blot. CFTR 837X or CFTR 837XΔF508 levels were quantifi ed by 
densitometry, and levels were normalized to control siRNA (si-Cont) reactions for each fragment. 
Antibodies directed against RMA1 and JB12 were used to monitor the impact of RNA 
interference addition on endogenous RMA1 and JB12 levels, respectively. Maturely glycosylated 
CFTR 837–1480 is designated as C-band, and the immaturely glycosylated form is indicated as 
B-band. 
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assembly of ΔF508-NBD1 into a complex with MSD1 and the R-
domain ( Rosser  et al. , 2008 ), and another is failure of ΔF508-NBD1 
to make interdomain contacts with intracellular loops on MSD2 
( Serohijos  et al. , 2008a ). The small molecule Corr-4a ( Pedemonte  et 
al. , 2005 ) and intragenic suppressor mutations ( Pissarra  et al. , 2008 ; 
 Loo  et al. , 2010 ) partially suppress kinetic defects in CFTRΔF508 
folding. Action of JB12 and the RMA1 E3 complex, however, remain 
an obstacle to highly effi cient folding of “corrected” CFTRΔF508. 
Thus combined attenuation of ERQC activity and suppression of ki-
netic defects in folding may be required to achieve therapeutically 
relevant increases in cell surface expression of CFTRΔF508. 
 JB12 and Hdj-2 are Hsp40 family members, and the domain 
structures and localization of each enable them to target Hsc70 to 
act in highly specifi c and opposing roles in the biogenesis of CFTR 
and CFTRΔF508. JB12 uses its J-domain and transmembrane re-
gion to facilitate nascent CFTR degradation via increasing Hsc70 
association with the B-form of CFTR and the RMA1 E3 complex. In 
stark contrast, Hdj-2, which is farnesylated and localized to the 
cytosolic face of the ER, directs Hsc70 to facilitate CFTR folding via 
transient association with ribosome-associated CFTR translation 
intermediates ( Meacham  et al. , 1999 ). These data provide an ex-
ample of how specialized Hsp40s can specify Hsc70 function at 
discrete steps in folding and degradation of the same polypeptide. 
Data presented also identify RMA1 as a member of an expanding 
family of E3 ubiquitin ligases that cooperate with Hsc70 to mediate 
aspects of protein QC ( Youker  et al. , 2004 ;  Han  et al. , 2007 ). 
 The following observations suggest that JB12 acts in conjunction 
with Hsc70 on the cytosolic face of the ER to select CFTR for RMA1-
dependent proteasomal degradation. First, elevation of JB12 ap-
proximately onefold over endogenous levels caused nearly all na-
scent CFTR and CFTRΔF508 to be targeted for proteasomal 
degradation. Second, JB12 kd increased CFTR folding effi ciency 
almost threefold and permitted a small pool of CFTRΔF508 to fold 
and escape the ER. Third, elevation of JB12 levels increased Hsc70 
binding to CFTRΔF508 severalfold. Fourth, mutation of the HPD 
motif in the J-domain, which is required for JB12 interactions with 
Hsc70, hindered JB12 function in CFTR degradation. Finally, JB12 
action is linked to RMA1 because it is present in complexes that 
contain RMA1 and RMA1 is required to observe JB12-dependent 
degradation of CFTR. 
 JB12 clearly plays a role in CFTR degradation, but its exact 
mechanism of action is not clear. One possibility is that JB12 and 
Hsc70 act in the selection of misfolded CFTR and CFTRΔF508 for 
RMA1-dependent degradation. Alternatively, JB12 and Hsc70 
could act indirectly to regulate RMA1 E3 action. Based on several 
observations presented, we favor an active role for JB12 in the se-
lection of misfolded CFTR for degradation. JB12 acts in a J-domain–
dependent manner to retain the B-form of CFTR in the ER under 
conditions in which proteasome activity is inhibited and when RMA1 
levels are depleted. Thus JB12 action is not dependent on RMA1, 
and JB12 appears to act prior to RMA1. JB12 does not appear to 
be required in the folding of proteins involved in CFTR folding or 
degradation because steady-state levels of the proteins such as 
Derlin-1, RMA1, Hsc70, and CHIP are unchanged upon JB12 kd. 
JB12-dependent accumulation of CFTR in the ER correlates with a 
severalfold increase in Hsc70 binding to CFTR. Thus we propose 
that JB12 acts with Hsc70 to facilitate ER retention and delivery of 
misfolded CFTR to components of the RMA1 E3 complex. 
 FIGURE 8:  Stepwise correction of CFTRΔF508 folding to wild-type 
levels through depletion of JB12 and intragenic suppression of 
intrinsic folding defects. (A) Western blot analysis of the C- and 
B-form of CFTR. (B) Pulse-chase analysis of CFTR biosynthetic 
maturation. Transfections with JB12 siRNA oligos and pcDNA3.1(+)-
CFTR, pcDNA3.1(+)-CFTRΔF508, or pcDNA3.1(+)-CFTRΔF508 V510D 
were performed as described in Materials and Methods. The siRNA 
samples were treated with DMSO or Corr-4a (5 µM) 24 h prior to 
being harvested. Steady-state levels of CFTR and CFTR mutants were 
determined by Western blot. In panel B, cells were labeled with 
 35 S-methionine for 20 min, and  35 S-CFTR was immunoprecipitated at 
the indicated time points. Bands B and C represent the immature and 
maturely glycosylated forms of CFTR, respectively. The B- and C-band 
levels for each reaction were quantifi ed by densitometry. The 
normalized C/B-band ratio is shown for (A), whereas in (B) the results 
were normalized to the relative amount of CFTR B-band at t = 0 for 
each condition. 
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of JB12 or CFTR were made using the QuikChange protocol 
(Stratagene, La Jolla, CA). Antibodies used in this study were as fol-
lows: α-CFTR MM13–4 (N-terminal tail epitope) and α-CFTR M3A7 
(NBD2 epitope) were obtained from Millipore (Billerica, MA); 
α-RMA1 (sc81716) was obtained from Santa Cruz Biotechnology 
(Santa Cruz, CA); α-tubulin, α-Derlin-1, α-HA, α-myc, and α-fl ag 
were purchased from Sigma (St. Louis, MO); α-Hdj2 was obtained 
from Thermo Fisher Scientifi c (St. Charles, MO); and α-Hsp/c70 
(SPA-757) was obtained from Nventa Biopharmaceuticals (San 
Diego, CA). JB12 antibody used in our studies was generated 
against JB12 1–243. The polyclonal α-CHIP antibody used was 
made against full-length recombinant CHIP protein. Polyclonal 
α-CFTR, generated against a GST fusion protein that contained 
CFTR residues 1–79, was a gift from Kevin Kirk (University of 
Alabama, Birmingham). Rabbit polyclonal α-BiP serum was provided 
to us by Christopher Nicchitta (Duke University). Bortezomib was 
purchased from LC Laboratories (Woburn, MA) and used at a fi nal 
concentration of 10 µM. Corr-4a was obtained from the North 
American Cystic Fibrosis Foundation through Robert Bridges 
(Rosalind Franklin University). 
 Protein purifi cation procedures 
 The following plasmids were used for overexpression of the indi-
cated proteins in the BL21 (DE3)  Escherichia coli strain: pET11a-
Hsc70 ( Meacham  et al. ,  1999 ), pET21a-JB12 1–243His 6 , and 
pET21a-JB12 1–243-QPDHis 6 . Hsc70 was purifi ed as described pre-
viously ( Meacham  et al. , 1999 ). JB12 1–243 and JB12 1–243-QPD 
were expressed by inducing BL21 (DE3) cells containing each con-
struct with 0.2 mM isopropyl 1-thio-β- D -galactopyranoside for 16 h 
at 30ºC. Cells were collected by centrifugation at 4000 rpm for 
10 min and then lysed in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl. 
JB12 1–243His 6 was purifi ed by metal chelate chromatography. 
All of these proteins were dialyzed into 20 mM K-HEPES (pH 7.4) 
containing 150 mM NaCl. 
 Analysis of purifi ed JB12 activity 
 Luciferase aggregation assays. Luciferase aggregation assays 
were carried out as previously described ( Rosser  et al. , 2007 ). Briefl y, 
fi refl y luciferase (Promega, Madison, WI) was diluted to a fi nal 
concentration of 100 nM in reactions containing 2 µM Hsc70 and 
4–8 µM JB12 1–243, where indicated, and 25 mM K-HEPES (pH 
7.4), 25 mM KCl, 5 mM MgCl 2 , 5 mM dithiothreitol (DTT), and 2 mM 
ATP. Aliquots of each reaction were removed and stored on ice to 
determine total (T) protein levels. Samples were incubated at room 
temperature for 10 min followed by a 10-min incubation at 42ºC. 
The supernatant (S) and pellet (P) samples were isolated by 
centrifugation at 20,000 rpm (Beckman Allegra 64R centrifuge ; 
4ºC, Beckman Coulter, Brea, CA). Samples were applied to a 
nitrocellulose membrane using a Bio-Rad slot blot apparatus 
(Hercules, CA), and luciferase-containing fractions were identifi ed 
by probing the membrane with a α-luciferase antibody (Cortex 
Biochemicals, San Leandro, CA). 
 Luciferase refolding assay. Refolding of chemically denatured 
fi refl y luciferase was conducted as previously described ( Rosser 
 et al. , 2007 ). Briefl y, luciferase was chemically denatured in 25 mM 
K-HEPES (pH 7.4), 50 mM KCl, 5 mM MgCl 2 , and 5 mM DTT 
containing 6 M guanidinium HCl. After being denatured, the 
luciferase-containing solution was diluted into a refolding buffer 
(25 mM K-HEPES [pH 7.4], 50 mM KCl, 5 mM MgCl 2 , and 1 mM 
ATP) that was supplemented with 1.6 µM Hsc70 and 3.2 µM JB12 
1–243 or Ydj1, where indicated. Aliquots were removed from the 
 Function of JB12 in ERQC raises questions about how it enters 
into complexes that contain nascent CFTR and CFTRΔF508. JB12 
contains a transmembrane domain and a J-domain that are required 
for it to promote CFTR degradation, but its N- and C-terminal ex-
tensions are dispensable for this function. Therefore the form of 
JB12 that is active in CFTR degradation does not appear to contain 
a canonical polypeptide-binding domain that recognizes water-sol-
uble proteins. Instead, JB12 may use its transmembrane region to 
associate with membrane-inserted domains of CFTR. Alternatively, 
JB12 may be a modular Hsp40 ( Mokranjac  et al. , 2003 ) that interacts 
with other partners that function in substrate binding. JB12 and 
Derlin-1 are isolated in complexes with Hsc70 and Derlin-1 binding 
to CFTR’s membrane domains has been implicated in the selection 
of CFTR and CFTRΔF508 for RMA1-dependent degradation 
( Younger  et al. , 2006 ). Thus it is conceivable that JB12 and Derlin-1 
act together as a modular Hsp40 to bind unassembled transmem-
brane domains of CFTR and to bring adjacent cytosolic domains 
into contact with Hsc70. This concept requires additional experi-
mental support, however. 
 On the basis of the cooperation of Hsc70 and CHIP in CFTR 
degradation ( Meacham  et al. , 2001 ), we initially surmised that JB12 
would assist in CHIP-dependent aspects of CFTR degradation. This  
interaction with CHIP remains a possibility, but we were unable to 
detect endogenous or overexpressed CHIP in complexes with JB12 
and Hsc70. In addition, overexpressed JB12 could fully stimulate 
CFTR degradation upon kd of CHIP, whereas kd of RMA1 hindered 
JB12 action. Comparison of experiments in which different proteins 
are knocked down is diffi cult because the threshold at which deple-
tion of a specifi c protein elicits an effect on the process under study 
is never clear. Thus we do not want to exclude the possibility that 
JB12 assists in CHIP-dependent steps in CFTR degradation, but we 
don’t have evidence to support a direct functional interaction be-
tween JB12 and CHIP. 
 JB12 and Hdj-2 are related to the respective yeast Hsp40s Hlj1 
and Ydj1 ( Walsh  et al. , 2004 ). When CFTR is expressed in yeast it is 
unable to fold and escape the ER, and all of the wild type and mu-
tant forms expressed are degraded ( Zhang  et al. , 2001 ). Analysis of 
deletion mutants reveals that the individual loss of Hlj1 or Ydj1 has 
no effect on CFTR degradation, but deletion of both Hlj1 and Ydj1 
slows turnover ( Youker  et al. , 2004 ). These results differ from data 
obtained with mammalian cells where depletion of JB12 alone dra-
matically slows CFTR turnover and increases folding and where de-
pletion of Hdj-2 alone blocks CFTR folding and accelerates 
CFTRΔF508 degradation. To help explain these data, it should be 
noted that an RMA1 homologue is not found in yeast, and the yeast 
ER folding environment is not suffi cient to support CFTR folding. 
Nevertheless, it is clear that Type I Hsp40s, such as Hdj-2 and Ydj1, 
help stabilize non-native CFTR in the ER. In addition, the ability of 
JB12-related proteins to function in QC of polytopic membrane 
proteins is conserved from yeast to humans. 
 MATERIALS AND METHODS 
 Plasmids, antibodies, and reagents 
 The plasmids used for cell transfection were as follows: 
pcDNA3.1(+)-CFTR, pcDNA3.1(+)-CFTRΔF508, pcDNA3.1(+)-fl ag-
RMA1, pcDNA3.1(+)-Derlin-1, pcDNA3.1(+)-CHIP-myc, pcDM8 2B4 
TCRα, pcDNA-ApoB48 ( Younger  et al. , 2006 ), and pcDNA3.1(+)-
HA-p97QQ ( Younger  et al. , 2004 ). JB12 cDNA was obtained from 
Open Biosystems (Huntsville, AL), and the coding sequence of JB12 
was subcloned into the pcDNA3.1(+) expression vector to generate 
pcDNA3.1(+)-HA-JB12, pcDNA3.1(+)-JB12-myc, and pcDNA3.1(+)-
GFP-JB12 overexpression constructs. Point and truncation mutants 
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were transferred to nitrocellulose membranes, and the membranes 
were probed with the designated antibodies. α-tubulin was used to 
indicate loading controls. Where indicated, bortezomib (10 µM fi nal 
concentration), Corr-4a (5 µM fi nal concentration), or dimethyl sul-
foxide (DMSO) was added to the cells 18 h after transfection, and 
the cells were incubated for 4 h with bortezomib and for 24 h with 
Corr-4a or DMSO prior to being analyzed by Western blot. 
 CFTR processing effi ciency was measured by pulse-chase analy-
sis. Eighteen hours after transfection, HEK293 cells were starved in 
methionine-free MEM (Sigma) for 20 min, pulse labeled for 20 min 
with  35 S-methionine (100 µCi per 35-mm well; 1200 Ci/mmol; MP 
Biomedicals, Irvine, CA ), and then chased for the indicated amount 
of time. Cells were then lysed in PBS buffer supplemented with 1% 
Triton (PBS-Tr 1%), 1 mM PMSF, and Complete Protease Inhibitor 
Cocktail (Roche). Soluble lysates were obtained by centrifugation at 
20,000 rpm for 10 min in a Beckman Allegra 64R centrifuge. Equal 
microgram quantities of cell lysate were subjected to IP by incuba-
tion with a polyclonal α-CFTR antibody directed against the N ter-
minus followed by addition of a 50% Protein G bead slurry. The 
beads were washed with PBS-Tr (1%) supplemented with 0.2% SDS, 
the bound CFTR was eluted with 2× SDS sample buffer, and 
the samples were heated at 55°C for 10 min. The samples were 
analyzed by SDS–PAGE and visualized by autoradiography. 
 RNA interference analysis 
 HEK293 cells were transfected with oligonucleotides directed at ei-
ther JB12 (sequence 1, CUAUCCUCAUCCUGAUUCU; sequence 2, 
CGCUAUACCUACCAGCAAA) for a fi nal concentration of 200 nM 
or with a fi nal concentration of 100 nM against RMA1 (sequence 1, 
GCGCGACCUUCGAAUGUAA; sequence 2, CGGCAAGAGUGUC-
CAGUAU) or CHIP (sequence 1, GGAGCAGGGCAAUCGUCUG; 
sequence 2, CCAAGCACGACAAGUACAU) by using the transfec-
tion reagent Lipofectamine 2000 (Invitrogen). A similar fi nal concen-
tration of a nonspecifi c siRNA control duplex (Dharmacon, Lafayette, 
CO ) was used for comparison for each siRNA reaction. Forty-eight 
hours later, 1 µg of pcDNA3.1(+)-CFTR or pcDNA3.1(+)-CFTR mu-
tants was introduced into the cells using Effectene as the transfec-
tion reagent. For steady-state analysis, the cells were harvested 24 h 
after the second transfection. SDS sample buffer (2×) was added to 
cell pellets, and after sonication the samples were normalized to 
contain the same total amount of protein. The reactions were re-
solved on SDS–PAGE gels and transferred to nitrocellulose mem-
branes. Then the membranes were probed with the indicated anti-
bodies. α-Tubulin was used to indicate loading controls. For 
pulse-chase analysis, the cells were allowed to recover for 18 h after 
the second transfection. The pulse-chase procedure used is similar 
to that described in the CFTR biogenesis section. 
 Similar to that described earlier in the text for HEK293 cells, 
CFBE cells were transfected with either the nonspecifi c siRNA 
control duplex or siRNA oligos directed against JB12 using 
Lipofectamine 2000. The CFBE cells were harvested 72 h after 
transfection, and CFTR steady-state levels were analyzed by 
Western blot. 
 The Hdj-2 shRNA construct (pGIPZ Hdj-2; V2LHS-132206) and 
the nonsilencing pGIPZ control (RHS4346) were purchased from 
Open Biosystems, and 6 µg of plasmid was transfected into HEK293 
cells per single well of a six-well plate by using Lipofectamine 2000 
as the transfection reagent. Puromycin (25 µg/ml) was added to the 
cells 18 h after transfection to isolate those cells that took up the 
pGIPZ constructs. Cells were grown in puromycin-containing me-
dium for 3 d before pcDNA3.1(+)-CFTR (1 µg) was introduced into 
these cells by a second transfection using Effectene. Eighteen hours 
folding reaction and mixed with luciferase assay reagent (Promega). 
Luciferase activity was measured with a Turner TD-20/20 Luminometer 
(Promega). 
 Cell culture and transfection 
 HEK293 cells (Stratagene, Santa Clara, CA) were maintained in 
DMEM (GIBCO ) supplemented with 10% fetal bovine serum (FBS; 
Hyclone, Logan, UT ) and antibiotics (penicillin at 100 U/ml and 
streptomycin at 100 µg/ml; GIBCO). CFBE cells stably expressing 
CFTR or CFTRΔF508 were cultured in minimum essential medium 
(MEM; GIBCO) containing 10% FBS, penicillin at 50 U/ml, strepto-
mycin at 50 µg/ml, and puromycin at 1 µg/ml to maintain expression 
of CFTR. All cell types were incubated at 37°C in an atmosphere of 
5% CO 2 . Cell transfections were performed using Effectene reagent 
(Qiagen, Chatsworth, CA) or Lipofectamine 2000 (Invitrogen). The 
empty pcDNA3.1(+) vector was used to ensure that equal micro-
gram quantities of DNA were used in all transfection reactions. Un-
less otherwise indicated, each individual Western blot, pulse-chase 
time point, or IP reaction was transfected into one well of a six-well 
plate. 
 Fluorescence microscopy 
 HEK293 cells were grown on coverslips and transfected with 
pcDNA3.1(+)-GFP-JB12 (100 ng). Eighteen hours post-transfection 
the cells were washed with phosphate-buffered saline (PBS), stained 
with ER-Tracker in PBS (0.5 µM; Invitrogen) for 15 min, fi xed with 4% 
paraformaldehyde in PBS for 12 min, and washed twice with PBS. 
The localization of GFP-JB12 and the ER were visualized using an 
Olympus IX81 motorized inverted microscope. Images were pro-
cessed with MetaMorph and Adobe Photoshop. 
 Subcellular localization of JB12 
 pcDNA3.1(+)-HA-JB12 (0.05 µg) was transfected into three wells of 
a six-well plate of HEK293 cells. The transfected cells were lysed 
18 h post-transfection with 1 ml of a buffer containing PBS, Com-
plete Protease Inhibitor Cocktail (Roche, Basel, Switzerland), 1 mM 
phenylmethylsulfonyl fl uoride (PMSF), and 2 mM DTT. Cell extracts 
were homogenized with 50 strokes by a Wheaton homogenizer on 
ice. The lysates were subjected to centrifugation at 12,000 ×  g for 
20 min at 4ºC, and the 12,000 ×  g supernatant was used for subse-
quent analysis. An aliquot was removed from the 12,000 ×  g super-
natant to show the level of total (T) HA-JB12 present. Next mem-
branes were pelleted via centrifugation at 100,000 ×  g for 30 min at 
4ºC. The membrane pellet was resuspended in PBS, and equivalent 
samples were incubated with 1.0 M NaCl, 0.1 M Na 2 CO 3 , or 1% 
Triton. Each sample was incubated on ice for 30 min prior to cen-
trifugation at 100,000 ×  g for 30 min at 4ºC. The supernatant (S) 
and pellet (P) fractions and the total (T) sample were analyzed by 
Western blot analysis with HA-antibody. Calnexin was used as a 
marker for ER membranes. 
 Analysis of CFTR biogenesis 
 Steady-state levels of CFTR and its mutants were determined by 
Western blot analysis. HEK293 cells were transiently transfected 
with 1 µg of the indicated pcDNA3.1(+)-CFTR plasmids. To analyze 
the effect of JB12 on CFTR levels, 5 ng of pcDNA3.1(+)-JB12-myc 
(which results in approximately a 1:1 ratio of overexpressed/endog-
enous JB12 levels) was also introduced into HEK293 cells. Twenty-
four hours after transfection, the cells were harvested, diluted with 
2× SDS sample buffer (100 mM Tris-HCl, pH 6.8; 4% SDS; 0.05% 
bromophenol blue; 20% glycerol), sonicated, and heated at 37°C 
prior to resolving the proteins on SDS–PAGE gels. The proteins 
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the addition of a 50% Protein G slurry, and incubations with beads 
were carried out for 30 min. For the co-IP reactions, the Protein 
G pellets were washed three times with PBS-Tr (1%), and the 
immunoprecipitated proteins were eluted in 2× SDS sample buffer 
at 55ºC for 10 min. The re-IP samples were washed three times with 
PBS-Tr (1%), samples were separated into fi ve equal volume aliquots, 
and 40 µl of 2× SDS sample buffer was added to each sample. Four 
of the samples were incubated at 55ºC, and the fi fth sample was 
incubated at 37ºC to elute the interacting proteins. Each sample 
was further diluted in 1 ml of PBS-Tr (1%) supplemented with 
Complete Protease Inhibitor, PMSF, 0.2% SDS, and 0.5% bovine 
serum albumin. The four samples that were heated at 55ºC were 
incubated with α-fl ag, α-Derlin-1, α-Hsp/c70, or no antibody, and 
the sample heated previously at 37ºC was incubated with α-CFTR 
(CFTR may aggregate when heated to >37ºC in SDS-sample buffer, 
possibly affecting CFTR interactions with the α-CFTR antibody). 
Samples were incubated with antibody for 30 min followed by a 
30-min incubation with a 50% Protein G slurry at 4ºC. The beads 
were washed twice with PBS-Tr (1%) supplemented with 0.2% SDS, 
and the immunoprecipitated proteins were eluted in 2× sample 
buffer at 55ºC for 10 min. The co-IP and re-IP samples were then 
analyzed by SDS–PAGE and visualized by autoradiography. 
 Image processing 
 X-ray fi lm was exposed to detect signals on Western blots and auto-
radiograms. It was then scanned with a Bio-Rad GS-670 Imaging 
Densitometer. The fi lm exposures used were in the linear range of 
Kodak Biomax XAR fi lm and were quantitated with Bio-Rad Quant-1 
Software. Images were exported to Adobe Photoshop and pro-
cessed. Images were then imported into Adobe Illustrator and used 
to build fi gures. In instances where lanes of gels are not shown in the 
order they were run, a white line has been placed in the fi gures. 
Titrations were carried out to assure that Westerns blots were devel-
oped in the linear range of the primary and secondary antibodies. 
later, the cells were either harvested for Western blot analysis or  35 S-
labeled for pulse-chase reactions. 
 CFTR ubiquitination analysis 
 HEK293 cells were transiently transfected with pcDNA3.1(+)-CFTR 
(1 µg) or pcDNA3.1(+)-CFTRΔF508 (1 µg) and combinations of 
pcDNA3.1(+)-JB12-myc (5 ng) and pcDNA3.1(+)-HA-p97QQ 
(0.2 µg). The cells were lysed 18 h post-transfection with PBS-Tr 
(1%) buffer that contained 1 mM PMSF and Complete Protease 
Inhibitor Cocktail. Soluble cell lysates were obtained by centrifuga-
tion at 20,000 rpm for 10 min in an Allegra 64R centrifuge. Input 
samples were taken to compare the total amount of protein in each 
sample. CFTR was isolated by IP with a polyclonal α-CFTR antibody 
followed by addition of a 50% Protein G bead slurry. The isolated 
CFTR–Protein G bead complex was washed with PBS-Tr (1%) 
supplemented with 0.2% SDS, the bound CFTR was eluted with 
2× sample buffer, and the samples were heated at 55ºC for 10 min. 
Samples were resolved on a 10% SDS–PAGE gel and transferred to 
a nitrocellulose membrane. The nitrocellulose membranes were 
probed with either α-CFTR or α-Ub to detect the ubiquitinated 
CFTR. 
 Co-IP of JB12 with ER QC factors 
 Western blot co-IPs. HEK293 cells were cotransfected with either 
pcDNA3.1(+)-JB12-myc (0.2 µg) and pcDNA3.1(+)-fl ag-RMA1 
(0.2 µg) or with pcDNA3.1(+)-HA-JB12 (0.2 µg) and pcDNA3.1(+)-
CHIP-myc (0.2 µg). The cells were lysed in a co-IP buffer (PBS-Tr 
[1%], Complete Protease Inhibitor Cocktail, and 1 mM PMSF) 18 h 
post-transfection, and the soluble cell lysates were obtained by cen-
trifugation at 20,000 rpm for 10 min in an Allegra 64R centrifuge. 
Input samples were taken for each reaction. Complexes were iso-
lated by IP with the indicated antibodies followed by addition of a 
50% Protein G bead slurry. The isolated complexes were washed 
with PBS-Tr (1%), eluted with 2× SDS sample buffer, and heated at 
55ºC for 10 min. The interacting proteins were separated on a SDS–
PAGE gel and transferred to a nitrocellulose membrane. Then the 
membranes were probed with the designated antibodies. 
 35 S-labeled co-IPs . Infl uence of HA-JB12 (0.05 µg) on CFTRΔF508 
(1 µg) and endogenous Hsc70 association in HEK293 cells was 
visualized via co-IP/re-IP analysis similar to that described previously 
( Meacham  et al. , 1999 ).  35 S-labeled cells were lysed in PBS-Tr (1%) 
supplemented with either 80 mM phosphocreatine, creatine 
phosphokinase at 500 µg/ml, and 5 mM Mg-ATP (+ ATP condition) 
or apyrase (− ATP condition) ( Meacham  et al. , 1999 ). CFTRΔF508 
was immunoprecipitated from cell extracts, and the levels of bound 
Hsc70 were visualized by re-IP of endogenous Hsc70. 
 Isolation of  35 S-labeled JB12/RMA1/Derlin-1/Hsc70 
degradation complex . Expression plasmids for HA-JB12 
(0.05 µg), fl ag-RMA1 (0.5 µg), Derlin-1 (0.005 µg), and CFTRΔF508 
(1 µg) were cotransfected into HEK293 cells. Next, 18 h post-
transfection the cells were starved in methionine-free MEM (Sigma) 
for 30 min followed by a pulse-labeling period of 60 min with 
 35 S-methionine. Cells from 36 individual 35-mm wells were pooled 
and lysed at 4ºC for 60 min in a co-IP buffer (PBS-Tr [1%], Complete 
Protease Inhibitor, and PMSF) prior to centrifugation at 20,000 rpm 
for 10 min in a Beckman Allegra 64R centrifuge. The cleared lysates 
were then divided with 10% of the total volume to be used for co-IP 
analysis while the remaining 90% was used for re-IP studies. The 
reactions were incubated at 4ºC for 30 min in the absence or 
presence of the α-HA antibody. This incubation was followed by 
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